English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/162526
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

The Efflux Pump SmeDEF Contributes to Trimethoprim- Sulfamethoxazole Resistance in Stenotrophomonas maltophilia

AuthorsMaría Blanca Sánchez, José Luis Martínez
Issue Date2015
CitationAntimicrobial Agents and Chemotherapy
AbstractTrimethoprim-sulfamethoxazole (co-trimoxazole) is one of the antimicrobials of choice for the treatment of Stenotrophomonas maltophilia infections. The analysis of mutants either lacking or overexpressing the efflux pump SmeDEF shows that this efflux pump contributes to intrinsic and acquired co-trimoxazole resistance in S. maltophilia. Since SmeDEF can extrude a variety of antibiotics, selection with such antimicrobials, including quinolones, might also select for S. maltophilia co-trimoxazole resistance
Publisher version (URL)http://aac.asm.org/content/59/7/4347.long
URIhttp://hdl.handle.net/10261/162526
DOI10.1128/AAC.00714-15.
Appears in Collections:(CNB) Artículos
Files in This Item:
File Description SizeFormat 
Antimicrob. Agents Chemother.-2015-Sánchez-4347-8.pdfArtículo145,74 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.